Antimicrobial Resistance: Too Much Study, Not Enough Action, No Time to Lose
We have known about the threat of antimicrobial resistance (AMR) for so long that it seems as though we should have solutions in hand by now to save lives. However, news from around the world supports the assertion that we are NOT doing nearly enough to prevent this insidious threat to human life. Morbidity rates are increasing and broad efforts, such as the AMR Review, seem to have fizzled out. One thing we know for sure is that solutions must be global and multifaceted to be effective. Governments must be involved, but the effort cannot succeed unless there is also participation from the private sector, educational institutions, researchers and clinicians. Smaller studies sponsored by non-governmental organizations, consumers and civil society can also play a role in finding solutions to the AMR dilemma.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.